Cargando…
Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
BACKGROUND—: The incidence and clinical significance of persistent T2 hyperintensity after acute ST-segment–elevation myocardial infarction (STEMI) is uncertain. METHODS AND RESULTS—: Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI: NCT02072850). Two hundred eighty-t...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753833/ https://www.ncbi.nlm.nih.gov/pubmed/29242240 http://dx.doi.org/10.1161/CIRCIMAGING.117.006586 |
_version_ | 1783290329475055616 |
---|---|
author | Carberry, Jaclyn Carrick, David Haig, Caroline Ahmed, Nadeem Mordi, Ify McEntegart, Margaret Petrie, Mark C. Eteiba, Hany Hood, Stuart Watkins, Stuart Lindsay, Mitchell Davie, Andrew Mahrous, Ahmed Ford, Ian Sattar, Naveed Welsh, Paul Radjenovic, Aleksandra Oldroyd, Keith G. Berry, Colin |
author_facet | Carberry, Jaclyn Carrick, David Haig, Caroline Ahmed, Nadeem Mordi, Ify McEntegart, Margaret Petrie, Mark C. Eteiba, Hany Hood, Stuart Watkins, Stuart Lindsay, Mitchell Davie, Andrew Mahrous, Ahmed Ford, Ian Sattar, Naveed Welsh, Paul Radjenovic, Aleksandra Oldroyd, Keith G. Berry, Colin |
author_sort | Carberry, Jaclyn |
collection | PubMed |
description | BACKGROUND—: The incidence and clinical significance of persistent T2 hyperintensity after acute ST-segment–elevation myocardial infarction (STEMI) is uncertain. METHODS AND RESULTS—: Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI: NCT02072850). Two hundred eighty-three STEMI patients (mean age, 59±12 years; 75% male) had cardiac magnetic resonance with T2 mapping performed at 2 days and 6 months post-STEMI. Persisting T2 hyperintensity was defined as infarct T2 >2 SDs from remote T2 at 6 months. Infarct zone T2 was higher than remote zone T2 at 2 days (66.3±6.1 versus 49.7±2.1 ms; P<0.001) and 6 months (56.8±4.5 versus 49.7±2.3 ms; P<0.001). Remote zone T2 did not change over time (mean change, 0.0±2.7 ms; P=0.837), whereas infarct zone T2 decreased (−9.5±6.4 ms; P<0.001). At 6 months, T2 hyperintensity persisted in 189 (67%) patients, who were more likely to have Thrombus in Myocardial Infarction flow 0 or 1 in the culprit artery (P=0.020), incomplete ST-segment resolution (P=0.037), and higher troponin (P=0.024). Persistent T2 hyperintensity was associated with NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration (0.57 on a log scale [0.42–0.72]; P=0.004) and the likelihood of adverse left ventricular remodeling (>20% change in left ventricular end-diastolic volume; 21.91 [2.75–174.29]; P=0.004). Persistent T2 hyperintensity was associated with all-cause death and heart failure, but the result was not significant (P=0.051). ΔT2 was associated with all-cause death and heart failure (P=0.004) and major adverse cardiac events (P=0.013). CONCLUSIONS—: Persistent T2 hyperintensity occurs in two thirds of STEMI patients. Persistent T2 hyperintensity was associated with the initial STEMI severity, adverse remodeling, and long-term health outcome. CLINICAL TRIAL REGISTRATION—: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02072850. |
format | Online Article Text |
id | pubmed-5753833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-57538332018-01-31 Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications Carberry, Jaclyn Carrick, David Haig, Caroline Ahmed, Nadeem Mordi, Ify McEntegart, Margaret Petrie, Mark C. Eteiba, Hany Hood, Stuart Watkins, Stuart Lindsay, Mitchell Davie, Andrew Mahrous, Ahmed Ford, Ian Sattar, Naveed Welsh, Paul Radjenovic, Aleksandra Oldroyd, Keith G. Berry, Colin Circ Cardiovasc Imaging Original Articles BACKGROUND—: The incidence and clinical significance of persistent T2 hyperintensity after acute ST-segment–elevation myocardial infarction (STEMI) is uncertain. METHODS AND RESULTS—: Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI: NCT02072850). Two hundred eighty-three STEMI patients (mean age, 59±12 years; 75% male) had cardiac magnetic resonance with T2 mapping performed at 2 days and 6 months post-STEMI. Persisting T2 hyperintensity was defined as infarct T2 >2 SDs from remote T2 at 6 months. Infarct zone T2 was higher than remote zone T2 at 2 days (66.3±6.1 versus 49.7±2.1 ms; P<0.001) and 6 months (56.8±4.5 versus 49.7±2.3 ms; P<0.001). Remote zone T2 did not change over time (mean change, 0.0±2.7 ms; P=0.837), whereas infarct zone T2 decreased (−9.5±6.4 ms; P<0.001). At 6 months, T2 hyperintensity persisted in 189 (67%) patients, who were more likely to have Thrombus in Myocardial Infarction flow 0 or 1 in the culprit artery (P=0.020), incomplete ST-segment resolution (P=0.037), and higher troponin (P=0.024). Persistent T2 hyperintensity was associated with NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration (0.57 on a log scale [0.42–0.72]; P=0.004) and the likelihood of adverse left ventricular remodeling (>20% change in left ventricular end-diastolic volume; 21.91 [2.75–174.29]; P=0.004). Persistent T2 hyperintensity was associated with all-cause death and heart failure, but the result was not significant (P=0.051). ΔT2 was associated with all-cause death and heart failure (P=0.004) and major adverse cardiac events (P=0.013). CONCLUSIONS—: Persistent T2 hyperintensity occurs in two thirds of STEMI patients. Persistent T2 hyperintensity was associated with the initial STEMI severity, adverse remodeling, and long-term health outcome. CLINICAL TRIAL REGISTRATION—: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02072850. Lippincott Williams & Wilkins 2017-12 2017-12-14 /pmc/articles/PMC5753833/ /pubmed/29242240 http://dx.doi.org/10.1161/CIRCIMAGING.117.006586 Text en © 2017 The Authors. Circulation: Cardiovascular Imaging is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Articles Carberry, Jaclyn Carrick, David Haig, Caroline Ahmed, Nadeem Mordi, Ify McEntegart, Margaret Petrie, Mark C. Eteiba, Hany Hood, Stuart Watkins, Stuart Lindsay, Mitchell Davie, Andrew Mahrous, Ahmed Ford, Ian Sattar, Naveed Welsh, Paul Radjenovic, Aleksandra Oldroyd, Keith G. Berry, Colin Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications |
title | Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications |
title_full | Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications |
title_fullStr | Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications |
title_full_unstemmed | Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications |
title_short | Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications |
title_sort | persistence of infarct zone t2 hyperintensity at 6 months after acute st-segment–elevation myocardial infarction: incidence, pathophysiology, and prognostic implications |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753833/ https://www.ncbi.nlm.nih.gov/pubmed/29242240 http://dx.doi.org/10.1161/CIRCIMAGING.117.006586 |
work_keys_str_mv | AT carberryjaclyn persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT carrickdavid persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT haigcaroline persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT ahmednadeem persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT mordiify persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT mcentegartmargaret persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT petriemarkc persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT eteibahany persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT hoodstuart persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT watkinsstuart persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT lindsaymitchell persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT davieandrew persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT mahrousahmed persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT fordian persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT sattarnaveed persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT welshpaul persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT radjenovicaleksandra persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT oldroydkeithg persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications AT berrycolin persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications |